Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Reinisch

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|March 3, 2015
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysisJ-F Colombel, W Reinisch, G J Mantzaris, et al.
Digestive Diseases and Sciences|March 19, 2024
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysisL Peyrin-Biroulet, P Bossuyt, D Bettenworth, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2014
[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH]H Fuchssteiner, K Nigl, A Mayer, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Review article: defining remission in ulcerative colitisS P L Travis, P D R Higgins, T Orchard, et al.
Gut|May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineG Vernier-Massouille, J Cosnes, M Lemann, et al.
Gut|November 25, 2003
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitisH Tilg, H Vogelsang, O Ludwiczek, et al.
Zeitschrift Fur Gastroenterologie|May 18, 2013
[Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology]S Angelberger, C Campregher, H Fuchssteiner, et al.
Science (New York, N.Y.)|February 7, 2001
Views of Earth's magnetosphere with the image satelliteJ L Burch, S B Mende, D G Mitchell, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|March 3, 2015
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysisJ-F Colombel, W Reinisch, G J Mantzaris, et al.
Digestive Diseases and Sciences|March 19, 2024
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysisL Peyrin-Biroulet, P Bossuyt, D Bettenworth, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2014
[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH]H Fuchssteiner, K Nigl, A Mayer, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Review article: defining remission in ulcerative colitisS P L Travis, P D R Higgins, T Orchard, et al.
Gut|May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineG Vernier-Massouille, J Cosnes, M Lemann, et al.
Gut|November 25, 2003
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitisH Tilg, H Vogelsang, O Ludwiczek, et al.
Zeitschrift Fur Gastroenterologie|May 18, 2013
[Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology]S Angelberger, C Campregher, H Fuchssteiner, et al.
Science (New York, N.Y.)|February 7, 2001
Views of Earth's magnetosphere with the image satelliteJ L Burch, S B Mende, D G Mitchell, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
Pageof 8